Quantitative pharmacology and individualized therapy strategies in development of therapeutic proteins for immune-mediated inflammatory diseases / edited by Honghui Zhou, Diane R. Mould.

Contributor(s):

Material type: Text

TextPublisher: Hoboken, NJ : Wiley, 2019Description: 1 online resourceContent type:

text

Media type:

computer

Carrier type:

online resource

ISBN:

9781119289210
9781119289227

Subject(s):

Additional physical formats: Print version:: Quantitative pharmacology and individualized therapy strategies in development of therapeutic proteins for immune-mediated inflammatory diseasesDDC classification:

616.97/806 23

LOC classification:

RC600

NLM classification:

WD 305

Summary: "Focused on quantitative pharmacology and individualized therapy for developing biotherapeutics in immune-mediated inflammatory diseases, this book discusses both theoretical and practical aspects and includes case studies illustrating applications in drug development. Provides frontline knowledge of using PK/PD modeling tools to address a variety of problems in development of therapeutic proteins. Reviews and discusses biomarkers, systems pharmacology, PBPK modeling, and target-mediated modeling, as translational tools. Helps readers understand disease progression and identify of mechanisms-based biomarkers with clinical relevance"--Provided by publisher.

Item type: BOOKS

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Collection	Call number	Status	Barcode
BOOKS	MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO	NFIC	616.97/806 (Browse shelf(Opens below))	Not for loan	EBS0127

Total holds: 0

"John Wiley & Sons Inc."--tp verso.

Includes bibliographical references and index.

"Focused on quantitative pharmacology and individualized therapy for developing biotherapeutics in immune-mediated inflammatory diseases, this book discusses both theoretical and practical aspects and includes case studies illustrating applications in drug development. Provides frontline knowledge of using PK/PD modeling tools to address a variety of problems in development of therapeutic proteins. Reviews and discusses biomarkers, systems pharmacology, PBPK modeling, and target-mediated modeling, as translational tools. Helps readers understand disease progression and identify of mechanisms-based biomarkers with clinical relevance"--Provided by publisher.

Description based on print version record and CIP data provided by publisher.

There are no comments on this title.

to post a comment.